Balyasny Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2393 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2330 |
|
|
2023
Q1 | – | Sell |
-364,068
| Closed | -$4.5M | – | 2783 |
|
|
2022
Q4 | $4.5M | Buy |
364,068
+336,332
| +1,213% | +$4.16M | 0.01% | 798 |
|
|
2022
Q3 | $387K | Buy |
27,736
+17,356
| +167% | +$242K | ﹤0.01% | 1642 |
|
|
2022
Q2 | $143K | Buy |
+10,380
| New | +$143K | ﹤0.01% | 1799 |
|
|
2022
Q1 | – | Sell |
-19,333
| Closed | -$315K | – | 2622 |
|
|
2021
Q4 | $315K | Sell |
19,333
-221,398
| -92% | -$3.61M | ﹤0.01% | 1502 |
|
|
2021
Q3 | $3.58M | Buy |
+240,731
| New | +$3.58M | 0.01% | 774 |
|
|
2020
Q2 | – | Sell |
-5,439
| Closed | -$342K | – | 1409 |
|
|
2020
Q1 | $342K | Sell |
5,439
-55,156
| -91% | -$3.47M | ﹤0.01% | 843 |
|
|
2019
Q4 | $7.51M | Buy |
+60,595
| New | +$7.51M | 0.04% | 445 |
|
|
2018
Q4 | – | Sell |
-22,000
| Closed | -$2.78M | – | 1644 |
|
|
2018
Q3 | $2.78M | Sell |
22,000
-23,534
| -52% | -$2.97M | 0.01% | 706 |
|
|
2018
Q2 | $3.82M | Buy |
+45,534
| New | +$3.82M | 0.02% | 609 |
|
|
2018
Q1 | – | Sell |
-50,716
| Closed | -$2.96M | – | 2106 |
|
|
2017
Q4 | $2.96M | Sell |
50,716
-90,684
| -64% | -$5.3M | 0.01% | 828 |
|
|
2017
Q3 | $8.21M | Buy |
141,400
+27,696
| +24% | +$1.61M | 0.03% | 479 |
|
|
2017
Q2 | $13.8M | Buy |
+113,704
| New | +$13.8M | 0.06% | 373 |
|
|
2017
Q1 | – | Sell |
-21,227
| Closed | -$2.31M | – | 1565 |
|
|
2016
Q4 | $2.31M | Buy |
21,227
+7,025
| +49% | +$763K | 0.01% | 685 |
|
|
2016
Q3 | $2.34M | Buy |
+14,202
| New | +$2.34M | 0.01% | 590 |
|